New England Journal of Medicine

Small study adds to growing hope CAR-T cell therapy could revolutionize autoimmune disease treatment
Stat
Wed, 02/21/24 - 10:47 pm
CAR-T
New England Journal of Medicine
autoimmune disease
Regeneron flashes ‘great advance' in the NEJM for that other cholesterol drug sitting at the FDA
Endpoints
Wed, 08/19/20 - 11:45 pm
Regeneron
inclisiran
RNAi
Novartis
New England Journal of Medicine
Harvard professors call on FDA to maintain review standards amid COVID-19
RAPS.org
Wed, 04/15/20 - 11:34 pm
Harvard
New England Journal of Medicine
FDA
drug approvals
COVID-19
pandemic
Harvard Professor's Attack On Pharma's Clinical Trials Is Absurd
Forbes
Tue, 09/18/18 - 09:56 am
Harvard
clinical trials
New England Journal of Medicine
Eisai's weight-loss drug proves safe, but delivers no heart benefit
Biopharma Dive
Mon, 08/27/18 - 10:45 pm
Eisai
Belviq
New England Journal of Medicine
Merck's 'landmark' Zetia data hits NEJM, giving a boost to all LDL-fighting meds
Fierce Biotech
Thu, 06/4/15 - 09:18 am
Merck
Zetia
New England Journal of Medicine
Vytorin
Celgene's Crohn's Disease Drug Candidate Highlighted in NEJM
TheStreet.com
Thu, 03/19/15 - 08:07 am
Celgene
Crohn's Disease
Mongersen
New England Journal of Medicine
Celgene's Abraxane Under Fire in NEJM Letter
TheStreet.com
Thu, 01/30/14 - 10:10 am
New England Journal of Medicine
Abraxane
Celgene
pancreatic cancer
breast cancer
lung cancer
Pharma R&D Cuts Hurting U.S. Competitive Standing
Forbes
Fri, 01/3/14 - 11:52 am
R&D
New England Journal of Medicine
NEJM Sheds Light On Payments To Doctors
Forbes
Tue, 06/11/13 - 09:30 am
physician payments
New England Journal of Medicine
Optimer Gets NEJM Power
Forbes
Thu, 02/3/11 - 11:10 am
New England Journal of Medicine
Optimer
fidaxomicin
Clostridium Difficile
Popular Bone Drugs Don't Raise Esophageal, Stomach Tumor Risk, Study Finds
Bloomberg
Tue, 08/10/10 - 07:07 pm
stomach cancer
New England Journal of Medicine
osteoporosis
Roche
Boniva
Merck
Fosamax
NEJM study cuts epilepsy meds' link to suicide
Fierce Pharma
Thu, 08/5/10 - 11:55 am
UCB Pharmaceuticals
Trileptal
suicide
Pfizer
Novartis
New England Journal of Medicine
Neurontin
Lamictal
Keppra
GSK
anti-seizure
NEJM Editorial Raises Questions About Dendreon’s Cancer Vaccine Study: Biotech's Latest Mishaps
Seeking Alpha
Mon, 08/2/10 - 10:03 am
New England Journal of Medicine
Provenge
Dendreon
prostate cancer
Dendreon Gets Some Respect
Forbes
Wed, 07/28/10 - 11:20 pm
Dendreon
Provenge
New England Journal of Medicine
prostate cancer
Street Elite Get Early Crack at Arena Study
TheStreet.com
Wed, 07/14/10 - 10:42 am
Arena Pharmaceuticals
New England Journal of Medicine
obesity
BLOOM
Results in The New England Journal of Medicine confirm Novartis drug Femara is superior to tamoxifen after breast cancer surgery
Fierce Biotech
Thu, 08/20/09 - 10:59 am
Novartis
New England Journal of Medicine
breast cancer
Femara
tamoxifen
NEJM: Put comparative effectiveness on drug labels
Fierce Pharma
Fri, 08/14/09 - 10:40 am
drug comparisons
New England Journal of Medicine